Milk components as cancer chemopreventive agents

Asian Pacific Journal of Cancer Prevention

Volumn 1, Issue 4, 2000, Pages 277-282

  Tsuda, Hiroyuki ^a   Sekine, Kazunori ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Lactoferrin; Milk components; Preventive agents; Whey protiens

Indexed keywords

EID: 2942545512     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (66)

1. Abdelali H, Cassand P, Soussotte V, et al. (1995). Effect of dairy products on initiation of precursor lesions of colon cancer on rats. Nutr Cancer, 24, 121-32.
2. Balansky R, Gyosheva B, Ganchev G, et al. (1999). Inhibitory effects of freeze-dried milk fermented by selected Lactobacillus bulgaricus strains on carcinogenesis induced by 1,2-dimethylhydrazine in rats and by diethylnitrosamine in hamsters. Cancer Lett, 147, 125-37
3. Benito E, Obrador A, Stiggelbout A, et al. (1990). A populationbased case-control study of colorectal cancer in Majorca. I. Dietary factors. Int J Cancer, 45, 69-76
4. Bezault J, Bhimani J, Wiprovnick P, Furmanski P. (1994). Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res, 54, 2310-2.
5. Biffi A, Coradini D, Larsen R, Riva L, Di Fronzo G. (1997). Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer, 28, 93-9.
6. Bounous G, Batist G, Gold P. (1991). Whey proteins in cancer prevention. Cancer Lett, 57, 91-4.
7. Bounous G, Papenburg R, Kongshavn PA, Gold P, Fleiszer D. (1988). Dietary whey protein inhibits the development of dimethylhydrazine induced malignancy. Clin Invest Med, 11, 213-7.
8. Boyd NF, Martin LJ, Noffel M. (1990) A meta-analysis of studies of dietary-fat and breast cancer risk. Br J Cancer, 68, 627-36.
9. Britigan BE, Serody JS, Cohen MS. (1994). The role of lactoferrin as an anti-inflammatory molecule. Adv Exp Med Biol, 357, 143-56.
10. Centonze S, Boeing H, Leoci C, Guerra V, Misciagna G. (1994) Dietary habits and colorectal cancer in a low-risk area: results from a population-based case-control study in Southern Italy. Nutr Cancer, 21, 233-46.
11. Chan JM, Giovannucci E, Andersson SO, et al. (1998). Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer. (Sweden). Cancer Causes Control, 9, 559-66.
12. Davies TW, Palmer CR, Ruja E, Lipscombe JM. (1996). Adolescent milk, dairy product and fruit consumption and testicular cancer. Br J Cancer, 74, 657-60.
13. Farley J, Loup D, Nelson M, et al. (1997). Neoplastic transformation of the endocervix associated with down regulation of lactoferrin expression, Mol Carcinogen, 20, 240-50.
14. Farrow DC, Davis S. (1990). Diet and the risk of pancreatic cancer in men. Am J Epidemiol, 132, 423-31.
15. Gahr M, Speer CP, Damerau B, Sawatzki G. (1991). Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J Leukocyte Biol, 49, 427-33.
16. Giovannucci E. (1998). Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control, 9, 567-82.
17. Giovannucci E, Rimm EB, Colditz GA, et al. (1993). A prospective study of dietary fat and risk of prostate cancer, J Natl Cancer Inst, 85, 1571-9.
18. Glinghammar B, Venturi M, Rowland IR, Rafter JJ. (1997). Shift from a dairy product-rich to a dairy product-free diet: influence on cytotoxicity and genotoxicity of fecal water-potential risk factors for colon cancer. Am J Clin Nutr, 66, 1277-82.
19. Hakansson A, Zhivotovsky B, Orrenius S, Sabharwal H, Svanborg C. (1995). Apoptosis induced by a human milk protein. Proc Natl Acad Sci USA, 92, 8064-8.
20. Hakkak R, Korourian S, Shelnutt SR, et al. (2000). Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats. Cancer Epidemiol Biomarkers Prev, 9, 113-7
21. Holt PR, Atillasoy EO, Gilman J, et al. (1998). Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial, JAMA, 280, 1074-9.
22. Iigo, M, Kuhara, T, Ushida, Y et al. (1999). Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis, 17, 35-40.
23. Ip C, Singh M, Thompson HJ, Scimeca JA. (1994). Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res, 54, 1212-5.
24. Ip C, Scimeca JA, Thompson H. (1995). Effect of timing and duration of dietary conjugated linoleic acid on mammary cancer prevention. Nutr Cancer, 24, 241-7.
25. Karagas MR, Tosteson TD, Greenberg ER, et al. (1998). Effects of milk and milk products on rectal mucosal cell proliferation in humans. Cancer Epidemiol Biomarkers Prev, 7, 757-66.
26. Kesteloot H, Lesaffre E, Joossens JV. (1991) Dietary fat, saturated animal fat, and cancer risk. Prev Med, 20, 226-36.
27. Kulkarni N, Reddy BS. (1995). Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial beta-glucuronidase. Proc Soc Exp Biol Med, 207, 278-83.
28. La Vecchia C, Decarli A, Fasoli M. (1988). Dietary vitamin A and the risk of intraepithelial and invasive cervical neoplasia, Gynecol Oncol, 30, 187-195.
29. La Vecchia C, Negri E, D'Avanzo B. (1990). Medical history, diet and pancreatic cancer, Oncology, 47, 463-6.
30. La Vecchia C, Negri E, D'Avanzo B. (1991). Dietary indicators of oral and pharyngeal cancer, Int J Epidemiol, 20, 39-44.
31. Levay PF, Viljoen M. (1995). Lactoferrin: a general review, Haematologica, 80, 252-267.
32. Lonnerdal B, Iyer S. (1995). Lactoferrin: molecular structure and biological function. Ann Rev Nutr, 15, 93-110.
33. Macquart-Moulin G, Riboli E, Cornje J. (1986). Case-control study on colorectal cancer and diet in Marseilles. Int J Cancer, 38, 183-91.
34. Masuda C, Wanibuchi H, Sekine K, et al. (2000). Chemopreventive effect of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis. Jpn J Cancer Res, 91, 582-8.
35. McIntosh GH. (1993). Colon cancer: dietary modifications required for a balanced protective diet. Prev Med, 22, 767-74.
36. McIntosh GH, Regester GO, Le LR, Royle PJ, Smithers GW. (1995). Dairy proteins protect against dimethylhydrazineinduced intestinal cancers in rats. J Nutr, 125, 809-16.
37. McCormick JA, Markey GM, Morris TC. (1991). Lactoferrininducible monocyte cytotoxicity for K562 cells and decay of natural killer lymphocyte cytotoxicity, Clin Exp Immunol, 83, 154-6.
38. Moore MA, Park CB, Tsuda H. (1998). Soluble and insoluble fiber influences on cancer development. Crit Rev Hematol Oncol, 27, 229-42.
39. Nishiya K, Horwitz DA. (1982). Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. J Immunol, 129, 2519-23.
40. Notani PN, Jayant K. (1987). Role of diet in upper aerodigestive tract cancers. Nutr Cancer, 10, 103-13.
41. Papenberg R, Bounous G, Fleiszer D, Gold P. (1990). Dietary milk proteins inhibit the development of dimethylhydrazine-induced malignancy, Tumour Biol. 11. (1990) 129-136.
42. Parodi PW. (1997) Cow's milk fat components as potential anticarcinogenic agents. J. Nutr. 127, 1055-1060.
43. Parodi PW. (1999). Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci, 82, 1339-49.
44. Pence BC. (1993). Role of calcium in colon cancer prevention: experimental and clinical studies. Mutat Res, 290 87-95.
45. Pence BC, Dunn DM, Zhao C, et al. (1996). Protective effects of calcium from nonfat dried milk against colon carcinogenesis in rats. Nutr Cancer, 25, 35-45.
46. Phillips R. (1975). Role of life-style and dietary habits in risk of cancer among Seventh-Day Adventists. Cancer Res, 35, 3513-3522.
47. Rice LJ, Chai YJ, Conti CJ, Willis RA, Locniskar MF. (1995). The effect of dietary fermented milk products and lactic acid bacteria on the initiation and promotion stages of mammary carcinogenesis. Nutr Cancer, 24, 99-109.
48. Sawatzki, G. Rich IN. (1989). Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells, 15, 371-385.
49. Schmelz EM, Sullards MC, Dillehay DL, Merrill AH Jr. (2000) Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazinetreated CF1 mice. J Nutr, 130, 522-7
50. Sekine K, Ushida Y, Kuhara T, et al. (1997). Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett, 121, 211-216.
51. Sekine K, Watanabe E, Nakamura J, et al. (1997). Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn J Cancer Res, 88, 523-6.
52. Shau H, Kim A, Golub SH. (1992). Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leukocyte Biol, 51, 343-9.
53. Shimizu N, Ikehara Y, Nozaki K, et al. (2000). Decreased proportion of pepsinogen-negative pyloric glands and antiHp antibodies in the Mongolian gerbil model. In 'Lactoferrin: Structure, Function and Applications', K Shimazaki et al. (Eds), Elsevier Science, Amsterdam, pp: 209-15.
54. Tanaka, T, Kawabata KH, Kohno, H et al. (2000). Chemopreventive effect of bovine lactoferrin on 4-nitroquinioline 1-oxide-induced tongue carcinogenesis in male F344 rats. Jpn J Cancer Res, 91, 25-33.
55. Tsuda H, Sekine K, Ushida Y, et al. (2000). Milk and dairy products in cancer prevention: focus on bovine lactoferrin. Mutat Res, 462, 227-233.
56. Tuyns AJ, Riboli E, Doornbos G. (1987). Diet and esophageal cancer in Calvados. (France), Nutr Cancer, 9, 81-92.
57. Ushida Y, Sekine K, Kuhara T, et al. (1998). Inhibitory effects of bovine lactoferrin on intestinal polyposis in the ApcMin mouse. Cancer Lett, 134, 141-5.
58. Ushida Y, Sekine K, Kuhara T, et al. (1999). Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat. Jpn J Cancer Res, 90, 262-7.
59. Verrault R, Chu J, Mandelson M, Shy K. (1989). A case control study of diet and invasive cervical cancer. Int J Cancer, 43, 34-8.
60. Wang W-P, Iigo M, Sato J, et al. (2000). Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn J Cancer Res, 91, 1022-7.
61. Webb PM, Bain CJ, Purdie DM, Harvey PW, Green A. (1998). Milk consumption, galactose metabolism and ovarian cancer. (Australia). Cancer Causes Control, 9, 637-44.
62. Weisburger JH, Rivenson A, Garr K, Aliaga C. (1997). Tea and milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer Lett, 114, 323-7.
63. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer 1997.
64. Yoo YC, Watanabe S, Watanabe R et al. (1997). Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res, 88, 184-90.
65. Ziegler RG, Brinton LA, Hamman RF, et al. (1990). Diet and risk of invasive cervical cancer among white women in the United States. Am J Epidemiol, 132, 432-45.
66. Ziegler RG, Jones CJ, Brinton LA. (1991). Diet and risk of in situ cervical cancer among white women in the United States. Cancer Causes Control, 2, 17-29.